GIL PRICE, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sarepta Therapeutics, Inc.

Filing Date Source Excerpt
2010-05-04 Dr. Price's experience in the clinical, research and commercial sectors in the fields of medicine and pharmaceuticals qualifies him for service as a member of the Board of Directors.
2011-05-20 Dr. Price is a clinical physician trained in internal medicine and has been CEO and CMO of Drug Safety Solutions, a provider of solutions for clinical and drug safety operations.
2012-06-13 Dr. Price is a clinical physician trained in internal medicine with a long-standing interest in drug development, adverse drug reactions, drug utilization and regulation.
2013-04-30 Dr. Price received a B.A. from the University of Rio Grande and a M.D. from the University of Santiago.
2014-04-30 Dr. Price is a clinical physician trained in internal medicine with a long-standing interest in drug development.
2015-04-30 Dr. Price is a clinical physician trained in internal medicine with a long-standing interest in drug development, adverse drug reactions, drug utilization and regulation.
2016-05-31 Dr. Price is a clinical physician trained in internal medicine with a long-standing interest in drug development, adverse drug reactions, drug utilization and regulation. Since 2008, he has been the Chief Executive Officer and Chief Medical Officer of Drug Safety Solutions, a provider of solutions for clinical and drug safety operations.

Data sourced from SEC filings. Last updated: 2025-08-30